Literature DB >> 27810337

PhyloOncology: Understanding cancer through phylogenetic analysis.

Jason A Somarelli1, Kathryn E Ware2, Rumen Kostadinov3, Jeffrey M Robinson4, Hakima Amri5, Mones Abu-Asab6, Nicolaas Fourie7, Rui Diogo8, David Swofford9, Jeffrey P Townsend10.   

Abstract

Despite decades of research and an enormity of resultant data, cancer remains a significant public health problem. New tools and fresh perspectives are needed to obtain fundamental insights, to develop better prognostic and predictive tools, and to identify improved therapeutic interventions. With increasingly common genome-scale data, one suite of algorithms and concepts with potential to shed light on cancer biology is phylogenetics, a scientific discipline used in diverse fields. From grouping subsets of cancer samples to tracing subclonal evolution during cancer progression and metastasis, the use of phylogenetics is a powerful systems biology approach. Well-developed phylogenetic applications provide fast, robust approaches to analyze high-dimensional, heterogeneous cancer data sets. This article is part of a Special Issue entitled: Evolutionary principles - heterogeneity in cancer?, edited by Dr. Robert A. Gatenby.
Copyright © 2016 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Cancer stratification; Cancer types; Clonal evolution; Tumor heterogeneity; Tumor trees

Mesh:

Substances:

Year:  2016        PMID: 27810337      PMCID: PMC9583457          DOI: 10.1016/j.bbcan.2016.10.006

Source DB:  PubMed          Journal:  Biochim Biophys Acta Rev Cancer        ISSN: 0304-419X            Impact factor:   11.414


  73 in total

1.  Molecular profiling of tumour budding implicates TGFβ-mediated epithelial-mesenchymal transition as a therapeutic target in oral squamous cell carcinoma.

Authors:  D H Jensen; E Dabelsteen; L Specht; A M K Fiehn; M H Therkildsen; L Jønson; J Vikesaa; F C Nielsen; C von Buchwald
Journal:  J Pathol       Date:  2015-06-01       Impact factor: 7.996

2.  A Hidden Markov Model approach to variation among sites in rate of evolution.

Authors:  J Felsenstein; G A Churchill
Journal:  Mol Biol Evol       Date:  1996-01       Impact factor: 16.240

3.  A simple method for estimating evolutionary rates of base substitutions through comparative studies of nucleotide sequences.

Authors:  M Kimura
Journal:  J Mol Evol       Date:  1980-12       Impact factor: 2.395

4.  The patterns and dynamics of genomic instability in metastatic pancreatic cancer.

Authors:  Peter J Campbell; Shinichi Yachida; Laura J Mudie; Philip J Stephens; Erin D Pleasance; Lucy A Stebbings; Laura A Morsberger; Calli Latimer; Stuart McLaren; Meng-Lay Lin; David J McBride; Ignacio Varela; Serena A Nik-Zainal; Catherine Leroy; Mingming Jia; Andrew Menzies; Adam P Butler; Jon W Teague; Constance A Griffin; John Burton; Harold Swerdlow; Michael A Quail; Michael R Stratton; Christine Iacobuzio-Donahue; P Andrew Futreal
Journal:  Nature       Date:  2010-10-28       Impact factor: 49.962

5.  Initiation-development modelling of allelic losses on chromosome 9 in multifocal bladder cancer.

Authors:  J Louhelainen; H Wijkström; K Hemminki
Journal:  Eur J Cancer       Date:  2000-07       Impact factor: 9.162

6.  Increased expression of genes converting adrenal androgens to testosterone in androgen-independent prostate cancer.

Authors:  Michael Stanbrough; Glenn J Bubley; Kenneth Ross; Todd R Golub; Mark A Rubin; Trevor M Penning; Phillip G Febbo; Steven P Balk
Journal:  Cancer Res       Date:  2006-03-01       Impact factor: 12.701

7.  Global DNA cytosine methylation as an evolving trait: phylogenetic signal and correlated evolution with genome size in angiosperms.

Authors:  Conchita Alonso; Ricardo Pérez; Pilar Bazaga; Carlos M Herrera
Journal:  Front Genet       Date:  2015-01-29       Impact factor: 4.599

8.  Molecular profiling of circulating tumor cells links plasticity to the metastatic process in endometrial cancer.

Authors:  Lorena Alonso-Alconada; Laura Muinelo-Romay; Kadri Madissoo; Antonio Diaz-Lopez; Camilla Krakstad; Jone Trovik; Elisabeth Wik; Dharani Hapangama; Lieve Coenegrachts; Amparo Cano; Antonio Gil-Moreno; Luis Chiva; Juan Cueva; Maria Vieito; Eugenia Ortega; Javier Mariscal; Eva Colas; Josep Castellvi; Maite Cusido; Xavier Dolcet; Hans W Nijman; Tjalling Bosse; John A Green; Andrea Romano; Jaume Reventos; Rafael Lopez-Lopez; Helga B Salvesen; Frederic Amant; Xavier Matias-Guiu; Gema Moreno-Bueno; Miguel Abal
Journal:  Mol Cancer       Date:  2014-09-27       Impact factor: 27.401

9.  Epigenetics and the evolution of Darwin's Finches.

Authors:  Michael K Skinner; Carlos Gurerrero-Bosagna; M Muksitul Haque; Eric E Nilsson; Jennifer A H Koop; Sarah A Knutie; Dale H Clayton
Journal:  Genome Biol Evol       Date:  2014-07-24       Impact factor: 3.416

10.  Applying unmixing to gene expression data for tumor phylogeny inference.

Authors:  Russell Schwartz; Stanley E Shackney
Journal:  BMC Bioinformatics       Date:  2010-01-20       Impact factor: 3.169

View more
  9 in total

1.  Neutral Theory and the Somatic Evolution of Cancer.

Authors:  Vincent L Cannataro; Jeffrey P Townsend
Journal:  Mol Biol Evol       Date:  2018-06-01       Impact factor: 16.240

2.  J-SPACE: a Julia package for the simulation of spatial models of cancer evolution and of sequencing experiments.

Authors:  Fabrizio Angaroni; Alex Graudenzi; Alessandro Guidi; Gianluca Ascolani; Alberto d'Onofrio; Marco Antoniotti
Journal:  BMC Bioinformatics       Date:  2022-07-08       Impact factor: 3.307

3.  PhyloMissForest: a random forest framework to construct phylogenetic trees with missing data.

Authors:  Diogo Pinheiro; Sergio Santander-Jimenéz; Aleksandar Ilic
Journal:  BMC Genomics       Date:  2022-05-18       Impact factor: 4.547

4.  Inferring Tumor Proliferative Organization from Phylogenetic Tree Measures in a Computational Model.

Authors:  Jacob G Scott; Philip K Maini; Alexander R A Anderson; Alexander G Fletcher
Journal:  Syst Biol       Date:  2020-07-01       Impact factor: 15.683

5.  Analysis of mutation, selection, and epistasis: an informed approach to cancer clinical trials.

Authors:  Jon F Wilkins; Vincent L Cannataro; Brian Shuch; Jeffrey P Townsend
Journal:  Oncotarget       Date:  2018-04-27

6.  An Integrative Systems Biology and Experimental Approach Identifies Convergence of Epithelial Plasticity, Metabolism, and Autophagy to Promote Chemoresistance.

Authors:  Shengnan Xu; Kathryn E Ware; Yuantong Ding; So Young Kim; Maya U Sheth; Sneha Rao; Wesley Chan; Andrew J Armstrong; William C Eward; Mohit Kumar Jolly; Jason A Somarelli
Journal:  J Clin Med       Date:  2019-02-07       Impact factor: 4.241

7.  Power and pitfalls of computational methods for inferring clone phylogenies and mutation orders from bulk sequencing data.

Authors:  Sayaka Miura; Tracy Vu; Jiamin Deng; Tiffany Buturla; Olumide Oladeinde; Jiyeong Choi; Sudhir Kumar
Journal:  Sci Rep       Date:  2020-02-26       Impact factor: 4.379

8.  Molecular Biology and Evolution of Cancer: From Discovery to Action.

Authors:  Jason A Somarelli; Heather Gardner; Vincent L Cannataro; Ella F Gunady; Amy M Boddy; Norman A Johnson; Jeffrey Nicholas Fisk; Stephen G Gaffney; Jeffrey H Chuang; Sheng Li; Francesca D Ciccarelli; Anna R Panchenko; Kate Megquier; Sudhir Kumar; Alex Dornburg; James DeGregori; Jeffrey P Townsend
Journal:  Mol Biol Evol       Date:  2020-02-01       Impact factor: 16.240

9.  Delineation of Tumor Migration Paths by Using a Bayesian Biogeographic Approach.

Authors:  Antonia Chroni; Tracy Vu; Sayaka Miura; Sudhir Kumar
Journal:  Cancers (Basel)       Date:  2019-11-27       Impact factor: 6.639

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.